Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06804785 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)

Name: Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS) — clinical trial record (NCT06804785)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HIT-PIRADS

StatusWithdrawn

PhaseNot specified

SponsorNorthwestern University

Started2025-08

View on ClinicalTrials.gov ↗

The purpose of this study is to develop a new way to diagnose prostate cancer through the use of artificial intelligence. The goal is for this new method to reduce delays in diagnoses and to avoid invasive procedures such as biopsies.

Amendment history 2 changes detected by DataLookout

2026-08-29

Trial status changed: Recruiting → Withdrawn

2026-08-29

Trial withdrawn: Due to funding issues the study did not move forward with prospective enrollment

Trial Details

NCT Number	NCT06804785
Lead Sponsor	Northwestern University Collaborators: National Cancer Institute (NCI)
Conditions	Prostate Cancer
Start Date	2025-08
Primary Completion	2027-05 (estimated)
Study Completion	2028-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-28